Kids & teens (for parents) · Indiana
Studies for children and teens in Indiana
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
37 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Indianapolis, IN + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Bristol-Myers Squibb
- Location
- Indianapolis, IN + 26 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
AbbVie
- Location
- Indianapolis, IN + 11 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Alkermes, Inc.
- Location
- Indianapolis, IN + 14 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Mannkind Corporation
- Location
- Indianapolis, IN + 9 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Indianapolis, IN + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Clarksville, IN + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 1
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
Pacira Pharmaceuticals, Inc
- Location
- Indianapolis, IN + 4 other US sites
- Eligibility basics
- Ages 0 mo–6
- RecruitingPhase 4
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
Bausch Health Americas, Inc.
- Location
- Indianapolis, IN + 3 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingHealthy volunteers
Feasibility of an Implementation Strategy for a Physical Activity Program in Rural Middle Schools
Indiana University
- Location
- Bloomfield, IN + 1 other US site
- Eligibility basics
- Ages 11–13
- RecruitingHealthy volunteersPhase 3
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
Ohio State University
- Location
- Bloomington, IN + 11 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingHealthy volunteers
Cerebral Physiology of NOWS
Indiana University
- Location
- Indianapolis, IN
- Eligibility basics
- Up to age 0 mo
- RecruitingHealthy volunteers
Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children
Purdue University
- Location
- West Lafayette, IN
- Eligibility basics
- Ages 10–12